ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TENX vs MNOV // ENTERPRISE SCALE & MARKET CAP

Tenax Therapeutics Inc. (NASDAQ) VS. Medicinova Inc (NASDAQ) • 15-METRIC TALLY: TENX 3 — MNOV 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TENX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TENX VS. MNOV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TENX MNOV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -14.24% — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — 68.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.23 0.20 +0.03 TENX /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 MNOV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.7 38.4 +6.27 TENX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 5.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $69.6M $68.9M $698.7K TENX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TENX REV MNOV REV TENX GROSS % MNOV GROSS % TENX FCF MNOV FCF
FY 2025 $0 $409.7K — — -$35.8M -$9.8M
FY 2024 $0 $0 — — -$14.8M -$10.6M
FY 2023 $0 $1.0M — — -$5.9M -$7.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TENX // BETA —
MNOV // BETA —